CA

Benoît S Landry

This inventor holds 1 USPTO granted patent. Top assignee: Dna Landmarks Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Benoît S Landry. Retrieved from https://idiyas.com/inventor/benoît-s-landry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Benoît S Landry: Innovator in Nucleic Acid Quantification

Introduction

Benoît S Landry is a notable inventor based in Canada, recognized for his contributions to the field of molecular biology. His innovative work focuses on improving methods for quantifying specific nucleic acid sequences, which is crucial for various applications in research and diagnostics.

Latest Patents

Benoît holds a patent for "Methods for relative quantification of specific nucleic acid sequences." This invention addresses the limitations of existing methods by providing a reliable way to quantify specific nucleic acid sequences within a sample. The method involves co-amplifying a target nucleic acid sequence alongside a known control sequence, allowing for accurate assessment of their relative amounts.

Career Highlights

Benoît is associated with Dna Landmarks Inc., where he applies his expertise in nucleic acid research. His work has significantly advanced the understanding and methodologies used in the quantification of nucleic acids, making a lasting impact in the field.

Collaborations

Benoît collaborates with talented individuals such as Martin Laforest and Nathalie Hubert, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Benoît S Landry's contributions to nucleic acid quantification exemplify the importance of innovation in scientific research. His patented methods enhance the reliability of nucleic acid analysis, paving the way for advancements in various biological applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…